IO Biotech is pleased to be invited to present at Bio€quity Europe, which this year is venued in Copenhagen. This is a much welcomed chance to elaborate on the company's scentific findings and current research to the financial community and international business development professionals.
Copenhagen, Denmark - January 5, 2016: IO Biotech today announced the successful completion of a €11 million Series A financing round. Participants were new investor Lundbeckfonden as well as existing investor Novo A/S.
On 14-15 March 2016, London sets the scene for Cambridge Healthtech Institute's Inaugural conference, Cancer Biotherapeutics, presenting new developments, in-depth discussions and focused short courses from academia and industry with a strong focus on immunotherapy.